Advertisement

Dementia Resources in Argentina: Policy, Services, and Statistics Overview—Up to Date

  • Pablo M. Bagnati
  • Fabian Roman
  • Marcela Bonafina
  • Andrew Blake
  • Ricardo F. AllegriEmail author
Chapter

Abstract

Argentina, the second largest country in South America, has traditionally been involved in caring for elderly. In 1971 the National Government created the Institute for the Elderly to take care of the social and medical needs of retired people with the program PAMI. This review has updated the local resources of dementia and the challenges that these face with regard to the issues associated with cognitive impairment in elderly people. Health care is shared between the public and private sectors. The distribution of resources and specialists (neurologists, psychiatrist, and geriatricians) is unequal most located in large cities. Facilities for accurate diagnosis are scarce; most of the memory clinics are in big cities like Buenos Aires, Rosario, and Cordoba. Early diagnosis is another challenge with the incorporation of the biomarkers of Alzheimer’s diseases (MRI scan, FDG-PET, amyloid-PET, and Aβ42, tau, and f-tau in cerebrospinal fluid). However the availability is limited to one center in Buenos Aires (FLENI Neurological Institute). ALMA (Association against Alzheimer’s Disease), a member of Alzheimer Disease International, is the local voluntary health organization in Alzheimer’s care and family support. In 2011, the Argentine Neurological Society launched the first dementia guideline for diagnosis and treatment. Although we have a long road ahead, the first steps taken by the organization of a dementia national plan constitute a hopeful challenge.

Keywords

Dementia Resources Policy Alzheimer Up-to-date 

References

  1. 1.
    Beck JC, Benson F, Scheibel AB, Spar JE, Rubenstein LZ. Dementia in the elderly: the silent epidemic. Ann Intern Med. 1982;97:231–41.CrossRefGoogle Scholar
  2. 2.
    World Health Organization and Alzheimer’s Disease International. Dementia: a public health priority. 2012. WHO Library Cataloguing. (www.who.int). Accessed 11/02/17.
  3. 3.
    INDEC. Instituto Nacional de Estadísticas y Censos. Censo Nacional de Población y Viviendas. 2010. Available at: http://www.indec.gov.ar. Accessed 11/02/17.
  4. 4.
    INDEC. Instituto Nacional de Estadísticas y Censos. Sistema Intregado de Estadísticas Sociodemográficas (SESD). 2017. http://www.indec.gov.ar/indicadores-sociodemograficos.asp#top. Accessed: 03/03/17.
  5. 5.
    World Bank. UNESCO Institute for Statistic: adult literacy rate, population 15+ years, both sexes. 2017. http://data.worldbank.org/indicator/SE.ADT.LITR.ZS?locations=AR. Accessed: 24/02/17.
  6. 6.
    UNFPA. Fondo de Población de las Naciones Unidas. ICPD goals and demographic indicators. 2016. http://www.unfpa.org/es/world-population-dashboard. Accessed: 25/02/17.
  7. 7.
    Bagnati PM, Kremer JL, Taragano FE, Allegri RF. Argentina. In: de Waal H, Lyketsos C, Ames D, O’Brien J, editors. Designing and delivering dementia services. USA: Wiley-Blackwell; 2013. p. 142.Google Scholar
  8. 8.
    ISSJP/PAMI. Instituto Nacional de Servicios Sociales para Jubilados y Pensionados. 2017. http://www.pami.org.ar/. Accessed: 23/07/2017.
  9. 9.
    Mangone C, Bueno A, Allegri R, Arizaga R, Nitrini R, et al. Behavioral and psychological symptoms of dementia in Latin America. Int Psychogeriatr. 2000;12(Suppl 1):415–8.CrossRefGoogle Scholar
  10. 10.
    Allegri RF. BPSD in Argentina. In: Brodaty H, Finkel F, editors. Behavioral and psychological symptoms of dementia (BPSD). Educational pack. Chicago: International Psychogeriatric Association (IPA); 2002.Google Scholar
  11. 11.
    Bartoloni L, Blatt G, Insua I, Furman M, González MA, Hermann B, Kesselman M, Massautis A, Reinado A, Senas A, Yavitz C, Lejarraga H, Nunes F, Arizaga RL, Allegri RF. A population-based study of cognitive impairment in socially vulnerable adults in Argentina. The Matanza Riachuelo study preliminary results. Dement Neuropsychologia. 2014;8(4):339–44.CrossRefGoogle Scholar
  12. 12.
    Alzheimer Disease International. World Alzheimer report. London: Copyright © Alzheimer’s Disease; 2016.Google Scholar
  13. 13.
    World Health Organization. World health report 2003 – shaping the future. Geneva: WHO; 2003.Google Scholar
  14. 14.
    Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7.CrossRefGoogle Scholar
  15. 15.
    Nitrini R, Bottino CM, Albala C. Prevalence of dementia in Latin America: a collaborative study of population-based cohorts. Int Psychogeriatr. 2009;21:622–30.CrossRefGoogle Scholar
  16. 16.
    Melcon MO, Mucci PD, Rizzardi PD. Demencias en Junín (B). Desde los certificados de defunción. Rev Neurol Arg. 1996;21:1–5.Google Scholar
  17. 17.
    Pages Larraya F, Grasso L, Mari G. Prevalencia de las demencias de tipo Alzheimer, demencias vasculares y otras demencias en la República Argentina. Rev Neurol Arg. 2004;29:148–53.Google Scholar
  18. 18.
    Arizaga RL, Gogorza RE, Allegri RF, et al. Deterioro cognitivo en mayores de 60 años en Cañuelas (Argentina). Resultados del Piloto del Estudio Ceibo (Estudio Epidemiológico Poblacional de Demencia). Rev Neurológica Argent. 2005;30:83–90.Google Scholar
  19. 19.
    Di Nella Y, Bartoloni L, Russo MJ, Sola M, Calvillo L, Negro L, Venesio S, Paz A, Melcon C, Del Monaco C, Melcon M, Allegri RF. Registros Centralizados de Patologías Cognitivas. Rev Argent Salud Pública. 2012;3(10):37–41.Google Scholar
  20. 20.
    Melcon CM, Bartoloni L, Katz M, Del Mónaco R, Mangone CA, Allegri RF, et al. Propuesta de un Registro Centralizado de casos con Deterioro Cognitivo en Argentina (ReDeCAr) basado en el Sistema Nacional de Vigilancia Epidemiológica. Neurol Argent. 2011;2(3):161–6.CrossRefGoogle Scholar
  21. 21.
    Katz M, Bartoloni LC, Melcon CM, Del Mónaco R, Mangone CA, Allegri RF, Melcon M, Grupo ReDeCAr. Primer Registro Centralizado de Patologias Cognitivas en Argentina (ReDeCAr). Resultados del Estudio Piloto. Bol Ministerio Salud Nación. 2011;5:11–51.Google Scholar
  22. 22.
    Allegri RF, Butman J, Arizaga RL, Machnicki G, Serrano CM, Taragano FE, Sarasola D, Lon L. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina. Int Psychogeriatr. 2007;19(4):705–18.CrossRefGoogle Scholar
  23. 23.
    Rojas G, Bartoloni L, Dillon C, Serrano CM, Iturry M, Allegri RF. Clinical and economic characteristics associated with direct costs of Alzheimer’s, frontotemporal and vascular dementia in Argentina. Int Psychogeriatr. 2011;23(4):554–61.CrossRefGoogle Scholar
  24. 24.
    Taragano F. Síntomas neuropsiquiátricos en la Enfermedad de Alzheimer. Rev ALMA (Asoc Lucha Mal de Alzheimer). 2011;1:10–1.Google Scholar
  25. 25.
    Taragano F, Mangone C, Comesaña DE. Prevalence of neuropsychiatric disorders in nursing homes. Rev Asoc Argent Establecimientos Geriátricos. 1995;1:1.Google Scholar
  26. 26.
    ISSJP/PAMI. Plan Estratégico Nacional para un Cerebro Saludable, enfermedad de Alzheimer y otras demencias. 2016. http://www.pami.org.ar/cerebrosaludable.php. Accessed: 23/07/2017.
  27. 27.
    Sarasola D, Taragano F, Allegri RF, Arizaga R, Bagnati P, Serrano CM, et al. Geriatric neuropsychiatry in Argentina. IPA Bull. 2006:10–9.Google Scholar
  28. 28.
    Rojas G, Serrano CM, Dillon C, Bartoloni L, Iturry M, Allegri RF. Use and abuse of drugs in cognitive impairment patients. Vertex. 2010;21(89):18–23.PubMedGoogle Scholar
  29. 29.
    Kremer J. Memory clinics in Argentina. Questionnaire. 2013. Available at: http://www.institutokremer.com.ar (last accessed on 20 Feb 2013) data on file.
  30. 30.
    Allegri RF, Arizaga RN, Bavec CV, Colli LP, Demey I, Fernández MC, Frontera SA, Garau ML, Jiménez JJ, Golimstok A, Kremer J, Labos E, Mangone CA, Ollari JA, Rojas G, Salmini O, Ure JA, Zuin DR. Enfermedad de Alzheimer. Guía de práctica clínica. Neurol Argent. 2011;3(2):120–37.CrossRefGoogle Scholar
  31. 31.
    Allegri RF, Russo MJ, Kremer J, Taragano FE, Brusco I, Ollari JA, Serrano CM, Sarasola D, Demey I, Arizaga RL, Bagnati P. Revisión de los nuevos criterios y recomendaciones para el diagnóstico de Deterioro Cognitivo Leve debido a Enfermedad de Alzheimer. Vertex. 2012;23(101):5–15.PubMedGoogle Scholar
  32. 32.
    Albert MS, De Kosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.CrossRefGoogle Scholar
  33. 33.
    Russo MJ, Bartoloni L, Iturry M, Serrano CM, Bagnatti P, Allegri RF. Encuesta sobre la enfermedad de Alzheimer en el contexto de los nuevos paradigmas diagnósticos. Neurol Argent. 2012;4(3):118–25.CrossRefGoogle Scholar
  34. 34.
    Bagnati P, Russo MJ, Bartoloni L, Iturry M, Allegri RF. Visión poblacional sobre la Enfermedad de Alzheimer y sus nuevos paradigmas diagnósticos y terapéuticos. Presentado en el Congreso Panamericano de Neurología, La Paz. Bolivia. 2012.Google Scholar
  35. 35.
    Smyth E. Saber que tengo o tendré Alzheimer… ¿para qué sirve? In: Bagnati P, et al., editors. Enfermedad de Alzheimer y otras demencias: Manual para la familia. Buenos Aires: Editorial Polemos; 2016. p. 143–6.Google Scholar
  36. 36.
    Bagnati P, Ramírez A, Cristaldi A, Cueto S, González Abad M. Envejecimiento Saludable y cerebro: Relevamiento de la consulta espontánea al neurólogo y al psiquiatra en una población representativa de adultos mayores en la Argentina: Estudio ES-UFASTA. Presentado en el 52° Congreso Argentino de Neurología, Mar del Plata, Argentina. 2015.Google Scholar
  37. 37.
    Allegri RF, Arizaga RL, Bavec C, Barreto MD, Brusco I, Colli L, Demey I, et al. Conducción de vehículos en el deterioro cognitivo y la demencia. Guía de Práctica Clínica. Neurol Argent. 2012;5(3):199–218.CrossRefGoogle Scholar
  38. 38.
    Sambade S, Crivelli L, Bagnati P. Conducción de automóviles y demencia. In: Bagnati P, et al., editors. Enfermedad de Alzheimer y otras demencias: Manual para la familia. Buenos Aires: Editorial Polemos; 2016. p. 165–74.Google Scholar
  39. 39.
    Mangone CA, Gorelick PB, Hier DB, Ganellen RJ. MRI in the elderly. Neurology. 1990;40(6):1011–2.CrossRefGoogle Scholar
  40. 40.
    Mangone CA, Hier DB, Gorelick PB, Ganellen RJ, Langenberg P, Boarman R, Dollear WC. Impaired insight in Alzheimer’s disease. J Geriatr Psychiatry Neurol. 1991;4(4):189–93.PubMedGoogle Scholar
  41. 41.
    Russo MJ, Gustafson S, Vázquez S, Surace E, Guinjoan S, Allegri RF, Sevlever G. Creation of the Argentina- Alzheimer disease neuroimaging initiative. Alzheimers Dement. 2014;10:S84–7.CrossRefGoogle Scholar
  42. 42.
    Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas F, Surace EI, Vázquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G. Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s disease neuroimaging initiative. Neuropsychiatr Dis Treat. 2016;12:2199–206.CrossRefGoogle Scholar
  43. 43.
    Chrem Mendez P, Cohen G, Russo MJ, Fernandez Suarez M, Nahas F, Russo G, Wierszylo CR, Paz S, Tabaschi L, Campos J, Amengual A, Kremer J, Guinjoan S, Leiguarda R, Sevlever G, Vazquez S, Allegri RF. Concordance between 11C-PIB-PET and clinical diagnosis in a memory clinic. Am J Alzheimers Dis Other Dement. 2015;30(6):599–606.CrossRefGoogle Scholar
  44. 44.
    Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri RF, Chatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, McDade E, Ringman JM, Rossor M, Salloway S, Schofield PR, Holtzman DM, Morris JC, Bateman RJ, Dominantly Inherited Alzheimer Network. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease. Brain. 2016;139(Pt 10):2766–77.CrossRefGoogle Scholar
  45. 45.
    Tang M, Ryman D, McDade E, Jasielec MS, Buckles BD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong CH, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, Ghetti B, Graff-Radford NR, Laske C, Martins RN, Masters CL, Mayeux RP, Ringman JM, Rossor MN, Salloway SP, Schofield PR, Morris JC, Bateman RJ. Dominantly Inherited Alzheimer Network. Neurological manifestations of autosomal dominant familial Alzheimer’s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 2016;15(13):1317–25.CrossRefGoogle Scholar
  46. 46.
    FLENI. Banco de Cerebros in www.fleni.org.ar/contenido1/242/Biobancos. 2017. Accessed 11/07/17.
  47. 47.
    Ukuwu H, Parma M, Guimaraes A, Fernando de Oliveira CF, Mas AP, Villeponteaux E. Clinical trials in latin America. In: Chin R, Bairu M, editors. Global clinical trials. USA: Elsevier; 2011.Google Scholar
  48. 48.
    Allegri RF, Bagnati PM, Brucki S, Nitrini R. South America’s AD clinical trials experience: lessons learned from Argentina and Brazil. In: Bairu M, Weiner M, editors. Dementia clinical trials. Amsterdam: Elsevier; 2013.Google Scholar
  49. 49.
    ClinicalTrials.gov. A service of the US National Institute of Health (USA). 2017. http://www.clinicaltrials.gov/ct2/results?term=Alzheimer&recr=Open. Accessed: 03/03/17.
  50. 50.
    Brodaty H, Finkel SI. Behavioral and psychological symptoms of dementia (BPSD), BPSD Educational Pack. Chicago: IPA (International Psychogeriatric Association); 2002.Google Scholar
  51. 51.
    Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatr Clin Neurosci. 2000;12:233–9.CrossRefGoogle Scholar
  52. 52.
    Pollero A, Gimenez M, Allegri RF, Taragano FE. Síntomas Neuropsiquiátricos en pacientes con enfermedad de Alzheimer. Vertex. 2004;15(55):5–9.PubMedGoogle Scholar
  53. 53.
    Berg L. Clinical dementia rating (CDR). Psychopharmacol Bull. 1988;24:637–9.PubMedGoogle Scholar
  54. 54.
    Demey I, Zimmerman M, Allegri RF, Serrano CM, Taragano FE. Trastornos conductuales en el deterioro cognitivo leve. Vertex. 2007;18:252–7.PubMedGoogle Scholar
  55. 55.
    Taragano FE, Allegri RF, Krupitzki H, Sarasola D, Serrano CM, Loñ L, Lyketsos C. Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry. 2009;70(4):584–92.CrossRefGoogle Scholar
  56. 56.
    Mangone C, Sanguinetti R, Baumann P, et al. Implications of feelings of burden on caregiver perception of the patient’s functional status. Dementia. 1993;4:287–93.PubMedGoogle Scholar
  57. 57.
    Allegri RF, Sarasola D, Serrano CM, Taragano FE, Arizaga RL, Butman J, Lon L. Neuropsychiatric symptoms as a predictor of Alzheimer’s disease. Neuropsychiatr Dis Treat. 2006;2(1):105–10.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Absher JR, Cummings JL. Cognitive and non-cognitive aspects of dementia syndromes: an overview. In: Burns A, Levy R, editors. Dementia. London: Chapman & Hall Medical; 1994.Google Scholar
  59. 59.
    Nagaratnam N, Lewis-Jones M, Scott D, et al. Behavioral and psychiatric manifestations in dementia patients in a community: caregiver burden and outcome. Alzheimer Dis Assoc Disord. 1998;12:330–4.CrossRefGoogle Scholar
  60. 60.
    Bagnati PM, Allegri RF, Kremer JL, Sarasola D. Enfermedad de Alzheimer y otras demencias: Manual para la familia. Buenos Aires: Editorial Polemos; 2016.Google Scholar
  61. 61.
    Bagnati P. The dementia caregiver. Vertex. 2010;21(Suppl):41–8.PubMedGoogle Scholar
  62. 62.
    Brodaty H, Finkel SI. The International Psychogeriatric Association (IPA) complete guides to BPSD – specialists guide. Module 7 cross-cultural and transnational. 2015. www.ipa-online.org. Accessed: 03/03/17.
  63. 63.
    ALMA. Asociación Lucha contra el Mal de Alzheimer y alteraciones semejantes de la República Argentina. 2015a. www.alma-alzheimer.org.ar. Accessed 12/12/15.
  64. 64.
    ALMA. Café con ALMA. Rev ALMA (Asoc Lucha contra la Enfermedad de Alzheimer). 2015b;6:11–3.Google Scholar
  65. 65.
    Medina N. El twinning Progam de ADI. Rev ALMA (Asoc Lucha contra la Enfermedad de Alzheimer). 2015;6:34–5.Google Scholar
  66. 66.
  67. 67.
    Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15:455–532.CrossRefGoogle Scholar
  68. 68.
    Baez S, Ibáñez A. Dementia in Latin America: an emergent silent tsunami. Front Aging Neurosci. 2016;8:253.CrossRefGoogle Scholar
  69. 69.
    World Health Organization. Ministerial conference on global action against dementia. 2015. http://www.who.int/mental_health/neurology/dementia/ministerial_conference_2015_report/en/. Accessed 20/07/2017.
  70. 70.
    World Health Organization. Global action plan on the public health response to dementia. 2017. http://www.who.int/mental_health/neurology/dementia/action_plan_consultation/en/. Accessed 20/07/2017.
  71. 71.
    Allegri RF. Primer Registro Centralizado de Patologías Cognitivas en Argentina (ReDeCAr). Resultados del Estudio Piloto. Publicación Ministerio Salud Argent. 2011;5:7–9.Google Scholar
  72. 72.
    Allegri RF, Román F, Blake A, Programa de Deterioro Cognitivo y Demencias. Dirección Nacional de Salud Mental y Adicciones. Ministerio de Salud de la Nación. Publicación Ministerio Salud. 2017;1:1–5.Google Scholar
  73. 73.
    Allegri RF, Roqué M, Bartoloni L, Rubin RK, et al. Deterioro Cognitivo, Alzheimer y otras demencias. Formación Profesional para el Equipo Socio- Sanitario. 1st ed. Buenos Aires: Ministerio de Desarrollo Social; 2015.Google Scholar
  74. 74.
    CyberSalud. Rev ALMA (Asoc Lucha contra la Enfermedad de Alzheimer). 2015;6:32–3.Google Scholar
  75. 75.
    Allegri RF, Arizaga RL, Bavec CV, Colli LP, Demey I, Fernández MC, Frontera SA, et al. Enfermedad de Alzheimer: Guía de práctica clínica. Neurol Argent. 2011;03:120–37.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Pablo M. Bagnati
    • 1
  • Fabian Roman
    • 2
  • Marcela Bonafina
    • 3
  • Andrew Blake
    • 2
  • Ricardo F. Allegri
    • 1
    Email author
  1. 1.Department of Cognitive Neurology, Neuropsychology and NeuropsychologyInstituto de Investigaciones Neurológicas “Raul Carrea” (FLENI)Buenos AiresArgentina
  2. 2.Department of Mental HealthMinisterio de Salud de la Ciudad de Buenos AiresBuenos AiresArgentina
  3. 3.Clinical and Forensic NeuropsychologyNew YorkUSA

Personalised recommendations